ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction.

Yamashiro, Kei; Nakao, Kazutaka; Ohba, Shigeo; Hirose, Yuichi*
Anticancer Research2020-3DOI: 10.21873/anticanres.14073
11阅读
引用收藏
分享

摘要

BACKGROUND/AIM: Temozolomide (TMZ) induces prolonged arrest of human glioma cells in the G2/M phase and inhibition of the G2 checkpoint intensifies the effect of TMZ. These findings suggest that the G2 checkpoint is linked to DNA repair mechanisms. MATERIALS AND METHODS: To clarify the mechanism of TMZ resistance, we established TMZ-resistant (TR) clones by serial treatment of U87MG cells with TMZ. We evaluated TMZ-induced cell cycle arrest and the effect of various G2 checkpoint inhibitors. RESULTS: We observed that longer exposure (over 6 months) to TMZ enriched the proportion of TR clones that underwent only minimal G2 arrest following TMZ treatment compared to short exposure (4 months) to TMZ. Expression of MSH6 was reduced in these clones. None of the G2 checkpoint inhibitors could resensitize TR clones to TMZ. CONCLUSION: Longer drug treatment may induce resistance of cells to DNA damaging agent(s) by means of mismatch repair modification.

学科与关键词

关键词
DNA mismatch repairG2 checkpointTemozolomideglioblastomaresistance
相关
加载中…
  • Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells
    Stewart P Johnson; Nancy Bullock; Francis Ali Osman; Darell D Bigner; Henry S FriedmanJournal of Biomedical Research, 2010, (06): 424-435.
  • Interaction of SENP6 with PINK1 Promotes Temozolomide Resistance in Neuroglioma Cells via Inducing the Mitophagy
    Wang, Y. W.; Jia, K. G.; Xing, H. J.; Pan, Y.; Zeng, C. S.; Chen, L.; Su, Q. J.; Shen, W. T.; Chen, J.; Chen, C.*; Cao, Q.*; Wang, Y. Y.MOLECULAR BIOLOGY, 2023, 57(6): 1228-1238.
  • Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
    Gu, Qiang; Li, Lang; Yao, Jiahao; Dong, Fa-yan; Gan, Yifan; Zhou, Shuhuai; Wang, Xinyu; Wang, Xue-feng*Frontiers in Oncology, 2023, 13: 1120103.
查看全部 →

发表信息

论文状态
公开发表
期刊
Anticancer Research
发表日期
2020-03
卷期
第 40 卷, 第 3 期
页码
1315-1323
DOI
10.21873/anticanres.14073
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
PUBMED

作者

  • Y

    Yamashiro, Kei (第一作者)

  • N

    Nakao, Kazutaka

查看全部 4 位作者收起作者
  • O

    Ohba, Shigeo

  • H

    Hirose, Yuichi (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417